Bridgefront Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,377	Closed	-$337K	–	593
2024 Q4	$337K	Buy	18,377 +2,740	+18%	+$50.3K	0.11%	326
2024 Q3	$240K	Buy	+15,637	New	+$240K	0.09%	401
2022 Q2	–	Sell	-9,266	Closed	-$224K	–	289
2022 Q1	$224K	Buy	+9,266	New	+$224K	0.28%	179